Biggest News Aggregation in the World
📰 Allogeneic News

Page 8 - Allogeneic News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allogeneic. Real-time updates on events, politics, business and more.

Cytovia Therapeutics and Cellectis Partner to Develop TALEN Gene-Edited iPSC-Derived  Natural Killer Cells Paris Stock Exchange:ALCLS

(MENAFN - GlobeNewsWire - Nasdaq) CAMBRIDGE, Mass. and NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic off-the-shelf gene-edited Natural Killer (NK) and Chimeric Antigen Receptor (CAR)-NK cells derived from induced pluripotent stem cells (iPSCs), and Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cell...
New York United States Israel General France General North Carolina United Kingdom
Source: menafn.com

Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial

(1) BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the successful completion of dosing of the first patient cohort (n=3) in a Phase I dose escalation study, evaluating the safety and efficacy of Tessas TT11X - Allogeneic CD30-CAR Epstein Barr Virus Specific T-cell (EBVST) therapy. The Phase 1 study b...
United States Baylor College Of Medicine Malcolm Brenner Carlos Ramos Allogeneic Vsts Ivand Horak

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science